A large propensity-matched retrospective cohort study showed a small but statistically significant 7% increase in new-onset ...

Dr Sunir Garg looks ahead to presentations on new developments in retinal eye disease treatments, medication risks, and ...

Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients.

EXTON, PA., June 20, 2024, July 24, 2024 (GLOBE NEWSWIRE) -- The American Society of Retinal Specialists (ASRS) annual meeting held last week in Stockholm, Sweden, showcased groundbreaking ...

Please provide your email address to receive an email when new articles are posted on . Retinal diseases were more prevalent in patients with alopecia areata, which could lead these patients to being ...

Human eyes, like a fingerprint, are unique. They can say so much without saying a word. They can communicate our needs, desires, fears, and so much more. Our eyes can reveal a lot about us as ...

Kato Pharmaceuticals, a privately-held clinical stage biopharmaceutical company, today announced that the FDA has approved the company’s investigational new drug (IND) application to conduct human ...

Golgi Neurosciences srl and Breye Therapeutics ApS have established a collaboration to develop Golgi’s P2X7 receptor antagonist program for retinal disorders. The companies have now closed the ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

In a genetic association study, investigators integrated data from genome-wide association studies of various disorders with retinal transcriptomic data. Findings revealed that the polygenic risk of ...

The study showed that nanoparticles injected into the retina can successfully stimulate the visual system and restore vision in mice with retinal diseases. The findings suggest that a new type of ...